Neurohormonal Blockade Therapy Associated With Improved Survival, Quality of Life in Patients With LVADs – The Cardiology Advisor

Neurohormonal blockade therapy was found to be associated with improved 4-year survival and quality of life after 2 years of treatment in patients with left ventricular assist devices.

Read the full article here

Related Articles